Cargando…

The Immune System’s Echo: The Phenomenon of Delayed Neurological Immune-Related Adverse Events (NirAEs) in Adjuvant Immunotherapy

The use of immune checkpoint inhibitors (ICIs) in early-stage settings has shown promise but can lead to chronic immune-related toxicities known as delayed immune-related adverse events (DIREs). These events, occurring after immunotherapy cessation, can affect various organ systems. Fatal immune-rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Gohel, Shruti, Kalarikkal, Zeid, Lavingia, Viraj, Mankad, Jigar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544656/
https://www.ncbi.nlm.nih.gov/pubmed/37790035
http://dx.doi.org/10.7759/cureus.44529
_version_ 1785114546218729472
author Gohel, Shruti
Kalarikkal, Zeid
Lavingia, Viraj
Mankad, Jigar
author_facet Gohel, Shruti
Kalarikkal, Zeid
Lavingia, Viraj
Mankad, Jigar
author_sort Gohel, Shruti
collection PubMed
description The use of immune checkpoint inhibitors (ICIs) in early-stage settings has shown promise but can lead to chronic immune-related toxicities known as delayed immune-related adverse events (DIREs). These events, occurring after immunotherapy cessation, can affect various organ systems. Fatal immune-related adverse events (irAEs) are relatively rare but significant. Diagnostic challenges exist in distinguishing DIREs from disease sequelae. Efforts are needed to develop evidence-based strategies for managing DIREs as long-term survival with ICIs becomes possible. This case study highlights delayed neurological immune-related adverse events (NirAEs) encountered during pembrolizumab treatment, emphasizing the need for accurate diagnosis and prompt management. Reporting practices in immunotherapy trials hinder accurate assessment of DIREs. Close monitoring, accurate diagnosis, and timely corticosteroid administration are vital for effective DIRE management.
format Online
Article
Text
id pubmed-10544656
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-105446562023-10-03 The Immune System’s Echo: The Phenomenon of Delayed Neurological Immune-Related Adverse Events (NirAEs) in Adjuvant Immunotherapy Gohel, Shruti Kalarikkal, Zeid Lavingia, Viraj Mankad, Jigar Cureus Neurology The use of immune checkpoint inhibitors (ICIs) in early-stage settings has shown promise but can lead to chronic immune-related toxicities known as delayed immune-related adverse events (DIREs). These events, occurring after immunotherapy cessation, can affect various organ systems. Fatal immune-related adverse events (irAEs) are relatively rare but significant. Diagnostic challenges exist in distinguishing DIREs from disease sequelae. Efforts are needed to develop evidence-based strategies for managing DIREs as long-term survival with ICIs becomes possible. This case study highlights delayed neurological immune-related adverse events (NirAEs) encountered during pembrolizumab treatment, emphasizing the need for accurate diagnosis and prompt management. Reporting practices in immunotherapy trials hinder accurate assessment of DIREs. Close monitoring, accurate diagnosis, and timely corticosteroid administration are vital for effective DIRE management. Cureus 2023-09-01 /pmc/articles/PMC10544656/ /pubmed/37790035 http://dx.doi.org/10.7759/cureus.44529 Text en Copyright © 2023, Gohel et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Neurology
Gohel, Shruti
Kalarikkal, Zeid
Lavingia, Viraj
Mankad, Jigar
The Immune System’s Echo: The Phenomenon of Delayed Neurological Immune-Related Adverse Events (NirAEs) in Adjuvant Immunotherapy
title The Immune System’s Echo: The Phenomenon of Delayed Neurological Immune-Related Adverse Events (NirAEs) in Adjuvant Immunotherapy
title_full The Immune System’s Echo: The Phenomenon of Delayed Neurological Immune-Related Adverse Events (NirAEs) in Adjuvant Immunotherapy
title_fullStr The Immune System’s Echo: The Phenomenon of Delayed Neurological Immune-Related Adverse Events (NirAEs) in Adjuvant Immunotherapy
title_full_unstemmed The Immune System’s Echo: The Phenomenon of Delayed Neurological Immune-Related Adverse Events (NirAEs) in Adjuvant Immunotherapy
title_short The Immune System’s Echo: The Phenomenon of Delayed Neurological Immune-Related Adverse Events (NirAEs) in Adjuvant Immunotherapy
title_sort immune system’s echo: the phenomenon of delayed neurological immune-related adverse events (niraes) in adjuvant immunotherapy
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544656/
https://www.ncbi.nlm.nih.gov/pubmed/37790035
http://dx.doi.org/10.7759/cureus.44529
work_keys_str_mv AT gohelshruti theimmunesystemsechothephenomenonofdelayedneurologicalimmunerelatedadverseeventsniraesinadjuvantimmunotherapy
AT kalarikkalzeid theimmunesystemsechothephenomenonofdelayedneurologicalimmunerelatedadverseeventsniraesinadjuvantimmunotherapy
AT lavingiaviraj theimmunesystemsechothephenomenonofdelayedneurologicalimmunerelatedadverseeventsniraesinadjuvantimmunotherapy
AT mankadjigar theimmunesystemsechothephenomenonofdelayedneurologicalimmunerelatedadverseeventsniraesinadjuvantimmunotherapy
AT gohelshruti immunesystemsechothephenomenonofdelayedneurologicalimmunerelatedadverseeventsniraesinadjuvantimmunotherapy
AT kalarikkalzeid immunesystemsechothephenomenonofdelayedneurologicalimmunerelatedadverseeventsniraesinadjuvantimmunotherapy
AT lavingiaviraj immunesystemsechothephenomenonofdelayedneurologicalimmunerelatedadverseeventsniraesinadjuvantimmunotherapy
AT mankadjigar immunesystemsechothephenomenonofdelayedneurologicalimmunerelatedadverseeventsniraesinadjuvantimmunotherapy